I have recorded at length the sad and sorry policy process that led the Morrison Government to hang its hat on the Astra Zeneca vaccine, which included politically driven timelines and dubious Liberal Party connections, mistakes and questionable data at the trial stage, and failure to anticipate all kinds of logistical challenges including for doctors.
More recently, Europe was seized by a medical panic around thrombosis risks that have now been isolated as applying to rare conditions that are easily treated.
Today BofA asks what the economic implications are for Europe (and therefore Australia) of its delayed vaccine rollout:
